Unknown

Dataset Information

0

The SWI/SNF Protein PBRM1 Restrains VHL-Loss-Driven Clear Cell Renal Cell Carcinoma.

ABSTRACT: PBRM1 is the second most commonly mutated gene after VHL in clear cell renal cell carcinoma (ccRCC). However, the biological consequences of PBRM1 mutations for kidney tumorigenesis are unknown. Here, we find that kidney-specific deletion of Vhl and Pbrm1, but not either gene alone, results in bilateral, multifocal, transplantable clear cell kidney cancers. PBRM1 loss amplified the transcriptional outputs of HIF1 and STAT3 incurred by Vhl deficiency. Analysis of mouse and human ccRCC revealed convergence on mTOR activation, representing the third driver event after genetic inactivation of VHL and PBRM1. Our study reports a physiological preclinical ccRCC mouse model that recapitulates somatic mutations in human ccRCC and provides mechanistic and therapeutic insights into PBRM1 mutated subtypes of human ccRCC.

SUBMITTER: Nargund AM 

PROVIDER: S-EPMC5431084 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

PBRM1 is the second most commonly mutated gene after VHL in clear cell renal cell carcinoma (ccRCC). However, the biological consequences of PBRM1 mutations for kidney tumorigenesis are unknown. Here, we find that kidney-specific deletion of Vhl and Pbrm1, but not either gene alone, results in bilateral, multifocal, transplantable clear cell kidney cancers. PBRM1 loss amplified the transcriptional outputs of HIF1 and STAT3 incurred by Vhl deficiency. Analysis of mouse and human ccRCC revealed co  ...[more]

Similar Datasets

Unknown Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma.
| S-EPMC3030920 | biostudies-literature
Unknown Inactivation of the PBRM1 tumor suppressor gene amplifies the HIF-response in VHL-/- clear cell renal carcinoma.
| S-EPMC5293026 | biostudies-literature
Unknown Loss of PBRM1 rescues VHL dependent replication stress to promote renal carcinogenesis.
| S-EPMC5725450 | biostudies-literature
Unknown Involvement of PBRM1 in VHL disease-associated clear cell renal cell carcinoma and its putative relationship with the HIF pathway.
| S-EPMC8548775 | biostudies-literature
Unknown Loss of PBRM1 and BAP1 expression is less common in non-clear cell renal cell carcinoma than in clear cell renal cell carcinoma.
| S-EPMC4274200 | biostudies-literature
Unknown MYC activation cooperates with Vhl and Ink4a/Arf loss to induce clear cell renal cell carcinoma.
| S-EPMC5472759 | biostudies-literature
Unknown PBRM1 loss is associated with increased sensitivity to MCL1 and CDK9 inhibition in clear cell renal cancer
| S-EPMC10869502 | biostudies-literature
Unknown FBXL6 depletion restrains clear cell renal cell carcinoma progression.
| S-EPMC9526225 | biostudies-literature
Unknown Clear Cell Renal Cell Carcinoma Subtypes Identified by BAP1 and PBRM1 Expression.
| S-EPMC5221690 | biostudies-literature
Unknown Evaluation of the role of downregulation of SNF5/INI1 core subunit of SWI/SNF complex in clear cell renal cell carcinoma development.
| S-EPMC5714755 | biostudies-literature